Functional Outcomes and Their Association With Physical Performance in Mechanically Ventilated Coronavirus Disease 2019 Survivors at 3 Months Following Hospital Discharge: A Cohort Study
Overview
Emergency Medicine
Authors
Affiliations
Objectives: We performed a comprehensive health assessment in mechanically ventilated coronavirus disease 2019 survivors to assess the impact of respiratory and skeletal muscle injury sustained during ICU stay on physical performance at 3 months following hospital discharge.
Design: Preregistered prospective observational cohort study.
Setting: University hospital ICU.
Patients: All mechanically ventilated coronavirus disease 2019 patients admitted to our ICU during the first European pandemic wave.
Measurements And Main Results: At 3 months after hospital discharge, 46 survivors underwent a comprehensive physical assessment (6-min walking distance, Medical Research Council sum score and handgrip strength), a full pulmonary function test, and a chest CT scan which was used to analyze skeletal muscle architecture. In addition, patient-reported outcomes measures were collected. Physical performance assessed by 6-minute walking distance was below 80% of predicted in 48% of patients. Patients with impaired physical performance had more muscle weakness (Medical Research Council sum score 53 [51-56] vs 59 [56-60]; p < 0.001), lower lung diffusing capacity (54% [44-66%] vs 68% of predicted [61-72% of predicted]; p = 0.002), and higher intermuscular adipose tissue area (p = 0.037). Reduced lung diffusing capacity and increased intermuscular adipose tissue were independently associated with physical performance.
Conclusions: Physical disability is common at 3 months in severe coronavirus disease 2019 survivors. Lung diffusing capacity and intermuscular adipose tissue assessed on CT were independently associated with walking distance, suggesting a key role for pulmonary function and muscle quality in functional disability.
Wintjens M, Aydeniz E, van Rosmalen F, Driessen R, Hulshof A, Bergmans D Crit Care Explor. 2025; 7(2):e1211.
PMID: 39899442 PMC: 11793260. DOI: 10.1097/CCE.0000000000001211.
Bhor S, Ladkat D, Shah N, Gondhalekar K, Chaudhari P, Khadilkar A Cureus. 2025; 16(12):e76283.
PMID: 39850191 PMC: 11754140. DOI: 10.7759/cureus.76283.
Parrotte K, Mercado L, Lappen H, Iwashyna T, Hough C, Valley T CHEST Crit Care. 2025; 2(3.
PMID: 39822343 PMC: 11737505. DOI: 10.1016/j.chstcc.2024.100084.
Padua K, Rosa K, Leal S, Oliveira Silva I, Oliveira R, Oliveira D J Clin Med. 2024; 13(18).
PMID: 39337028 PMC: 11432126. DOI: 10.3390/jcm13185542.
Koo B, Choi H, Choi H, Shin H, Won J, Hong S Medicine (Baltimore). 2024; 103(22):e38284.
PMID: 39259107 PMC: 11142803. DOI: 10.1097/MD.0000000000038284.